The University of Chicago Header Logo

Connection

Herbert T. Abelson to Methotrexate

This is a "connection" page, showing publications Herbert T. Abelson has written about Methotrexate.
Connection Strength

0.522
  1. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol. 1983 Mar; 1(3):208-16.
    View in: PubMed
    Score: 0.054
  2. High-dose methotrexate in osteogenic sarcoma. Natl Cancer Inst Monogr. 1981 Apr; (56):201-6.
    View in: PubMed
    Score: 0.047
  3. High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results. Cancer Treat Rep. 1981; 65 Suppl 1:99-106.
    View in: PubMed
    Score: 0.046
  4. Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep. 1981; 65 Suppl 1:137-40.
    View in: PubMed
    Score: 0.046
  5. Natural resistance to methotrexate in human melanomas. J Invest Dermatol. 1980 Oct; 75(4):357-9.
    View in: PubMed
    Score: 0.045
  6. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate. Biochem Pharmacol. 1980 Aug 15; 29(16):2241-5.
    View in: PubMed
    Score: 0.045
  7. Methotrexate di-n-butyl ester effects on thymidine metabolism. Biochem Pharmacol. 1979 Oct 15; 28(20):3069-74.
    View in: PubMed
    Score: 0.042
  8. Methotrexate and central nervous system toxicity. Cancer Treat Rep. 1978 Dec; 62(12):1999-2001.
    View in: PubMed
    Score: 0.040
  9. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics. Cancer Treat Rep. 1978 Oct; 62(10):1549-52.
    View in: PubMed
    Score: 0.040
  10. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity. Cancer Res. 1978 Aug; 38(8):2408-12.
    View in: PubMed
    Score: 0.039
  11. Pharmacologic studies on the dibutyl and gamma-monobutyl esters of methotrexate in the rhesus monkey. Cancer Chemother Pharmacol. 1982 Dec; 10(1):55-61.
    View in: PubMed
    Score: 0.013
  12. Adjuvant chemotherapy for osteosarcoma: a decade of experience. Surg Clin North Am. 1981 Dec; 61(6):1379-89.
    View in: PubMed
    Score: 0.012
  13. A thin-layer chromatographic method for separation of thymidine and deoxyuridine nucleotides. Anal Biochem. 1980 Jul 01; 105(2):311-8.
    View in: PubMed
    Score: 0.011
  14. Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem Pharmacol. 1980 Feb 15; 29(4):648-52.
    View in: PubMed
    Score: 0.011
  15. Identification of dihydrofolate reductase in human central-nervous-system tumours. Lancet. 1978 Jan 28; 1(8057):184-5.
    View in: PubMed
    Score: 0.009
  16. Identification of dihydrofolate reductase in rabbit brain. Biochem Pharmacol. 1977 Aug 15; 26(16):1507-11.
    View in: PubMed
    Score: 0.009
  17. Osteosarcoma: fifteen years later. N Engl J Med. 1985 Dec 26; 313(26):1637-43.
    View in: PubMed
    Score: 0.004
  18. Lack of dihydrofolate reductase in human tumor and leukemia cells in vivo. Cancer Drug Deliv. 1985; 2(2):133-8.
    View in: PubMed
    Score: 0.004
  19. Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy. J Clin Oncol. 1983 Apr; 1(4):251-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.